Rivaroxaban (Xarelto)

DRUG3 trials

Sponsors

University of Michigan, Bayer, Children's Hospital of Fudan University

Conditions

Atrial FibrillationComplications; ArthroplastyCoronary Artery AneurysmKawasaki DiseasePilot StudyRivaroxaban

Phase 4

Evaluation of Wound Drainage After Knee or Hip Arthroplasty

WithdrawnNCT02054936

University of MichiganComplications; Arthroplasty

Start: 2014-03-31End: 2016-02-29Updated: 2015-12-07

Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease

RecruitingNCT06978439

Children's Hospital of Fudan UniversityCoronary Artery Aneurysm, Kawasaki Disease, Pilot Study +1

Start: 2024-01-10End: 2025-12-31Target: 10Updated: 2025-09-08

Unknown Phase

Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

CompletedNCT04249401

BayerAtrial Fibrillation

Start: 2020-03-01End: 2023-09-30Updated: 2024-08-01